These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9918434)

  • 21. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin.
    Ahmad J; Dodson SF; Demetris AJ; Fung JJ; Shakil AO
    Liver Transpl; 2001 Oct; 7(10):863-9. PubMed ID: 11679984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and clinical significance of GB virus type C/hepatitis G virus coinfection in patients with chronic hepatitis C undergoing antiviral therapy.
    Hofer H; Aydin I; Neumueller-Guber S; Mueller C; Scherzer TM; Staufer K; Steindl-Munda P; Wrba F; Ferenci P
    J Viral Hepat; 2011 Jul; 18(7):513-7. PubMed ID: 20565572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GB virus C/hepatitis G virus infection in KwaZulu Natal, South Africa.
    Sathar MA; Soni PN; Naicker S; Conradie J; Lockhat F; Gouws E
    J Med Virol; 1999 Sep; 59(1):38-44. PubMed ID: 10440806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Viral co-infections in hepatitis C: HBV, HBV-C/HGV and TTV studies].
    Pár A; Takács M; Brojnás J; Berencsi G; Paál M; Horányi M; Miseta A; Hegedüs G; Mózsik G; Hunyady B
    Orv Hetil; 2004 May; 145(19):987-92. PubMed ID: 15181733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and clinical significance of HGV/GBV-C infection in patients with chronic hepatitis B or C.
    Yang JF; Dai CY; Chuang WL; Lin WY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Tsai JF; Chang WY; Yu ML
    Jpn J Infect Dis; 2006 Feb; 59(1):25-30. PubMed ID: 16495630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Profiles of GBV-C/hepatitis G virus markers in patients coinfected with hepatitis C virus.
    Sauleda S; Reesink HJ; Esteban JI; Hess G; Esteban R; Guardia J
    J Med Virol; 1999 Sep; 59(1):45-51. PubMed ID: 10440807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis G virus and human immunodeficiency virus coinfection: response to interferon-alpha therapy.
    Lau DT; Miller KD; Detmer J; Kolberg J; Herpin B; Metcalf JA; Davey RT; Hoofnagle JH
    J Infect Dis; 1999 Oct; 180(4):1334-7. PubMed ID: 10479167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of GBV-C/hepatitis G virus RNA and E2 antibody among subjects infected with human immunodeficiency virus type 1 after parenteral or sexual exposure.
    Bourlet T; Guglielminotti C; Evrard M; Berthelot P; Grattard F; Frésard A; Lucht FR; Pozzetto B
    J Med Virol; 1999 Aug; 58(4):373-7. PubMed ID: 10421404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retreatment of non-responder or relapser chronic hepatitis C patients with interferon plus ribavirin vs interferon alone.
    Milella M; Santantonio T; Pietromatera G; Maselli R; Casalino C; Mariano N; Genchi C; Pastore G
    Ital J Gastroenterol Hepatol; 1999 Apr; 31(3):211-5. PubMed ID: 10379482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta.
    Asahina Y; Izumi N; Uchihara M; Noguchi O; Tsuchiya K; Hamano K; Kanazawa N; Itakura J; Miyake S; Sakai T
    Hepatology; 2001 Aug; 34(2):377-84. PubMed ID: 11481623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of treatment with alpha-interferon on hepatitis G/GBV-C viraemia. The CONSTRUCT Group.
    Jarvis LM; Bell H; Simmonds P; Hawkins A; Hellum K; Harthug S; Maeland A; Ritland S; Myrvang B; von der Lippe B; Raknerud N; Skaug K
    Scand J Gastroenterol; 1998 Feb; 33(2):195-200. PubMed ID: 9517532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of interferon treatment response with GBV-C/HGV genomic RNA and anti-envelope 2 protein antibody.
    Tanaka T; Hess G; Schlueter V; Zdunek D; Tanaka S; Kohara M
    J Med Virol; 1999 Apr; 57(4):370-5. PubMed ID: 10089049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term follow-up of hepatitis G virus/GB virus C replication in liver during and after interferon therapy in patients coinfected with hepatitis C and G viruses.
    Shindo M; Arai K; Okuno T
    J Gastroenterol; 1999 Dec; 34(6):680-7. PubMed ID: 10588184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon-alpha therapy in patients dually infected with hepatitis C virus and GB virus C/hepatitis G virus--virological response of HGV and pretreatment HGV viremia level.
    Orito E; Mizokami M; Yasuda K; Sugihara K; Nakamura M; Mukaide M; Ohba KI; Nakano T; Kato T; Kondo Y; Kumada T; Ueda R; Iino S
    J Hepatol; 1997 Oct; 27(4):603-12. PubMed ID: 9365035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of two reverse transcription polymerase reaction assays (GEN ETI-K HGV RNA and LCx GBV-C assay) for the detection of GB virus C/hepatitis G virus RNA in clinical samples.
    García F; Garcia F; López I; Bernal C; Hernandez J; García-Valdecasas J; Piédrola G; Maroto C
    J Basic Microbiol; 2000; 40(1):25-32. PubMed ID: 10746196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GB virus C (GBV-C) infection in patients with chronic hepatitis C. Influence on liver disease and on hepatitis virus behaviour: effect of interferon alfa therapy.
    Pawlotsky JM; Roudot-Thoraval F; Muerhoff AS; Pellerin M; Germanidis G; Desai SM; Bastie A; Darthuy F; Rémiré J; Zafrani ES; Soussy CJ; Mushahwar IK; Dhumeaux D
    J Med Virol; 1998 Jan; 54(1):26-37. PubMed ID: 9443106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of ribavirin on dynamics of hepatitis C viremia in interferon alpha-treated patiens with response or no response].
    Berg T; Kaul T; Naumann U; Wiedenmann B; Hopf U
    Z Gastroenterol; 2000 Nov; 38(11):881-6. PubMed ID: 11132533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe exacerbation of liver disease during pregnancy in a thalassemic GBV-C/HGV-positive patient and neonatal hepatitis in offspring.
    Horsmans Y; Karayiannis P; Christophe JL; Pickering JM; Debauche C; Cornu C; Rahier J; Hess G; Thomas HC; Geubel AP
    J Med Virol; 1999 Feb; 57(2):122-5. PubMed ID: 9892395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GBV-C/HGV infection in children with chronic hepatitis C.
    Komatsu H; Fujisawa T; Inui A; Sogo T; Morinishi Y; Miyagawa Y; Inui M
    J Med Virol; 1999 Oct; 59(2):154-9. PubMed ID: 10459149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to interferon of GB virus C and hepatitis C virus in patients with chronic hepatitis.
    Inoue T; Sakamoto M; Akahane Y; Okamoto H; Miyakawa Y; Mayumi M
    Am J Gastroenterol; 1997 Nov; 92(11):1981-5. PubMed ID: 9362176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.